Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis

NCT01191996 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Secondary Progressive Multiple Sclerosis
Primary Progressive Multiple Sclerosis

Interventions

BIOLOGICAL: MIS416

Sponsor

Innate Immunotherapeutics

Collaborators

[object Object]
[object Object]